Global RNAi for Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 10, 2020 | 189 PAGES | REPORT CODE: CMM337341

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

The RNAi for Therapeutic is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period. The research provides insights for the global RNAi for Therapeutic market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the RNAi for Therapeutic industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global RNAi for Therapeutic Market Segmentations:

By Players:

Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

By Types:

siRNA
miRNA
shRNA

By End-User:

Cancer
Cardiovascular
HBV
Other

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Market
1.3 Market Segmentation by Type

1.3.1 Global RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
1.3.2 Global RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
1.3.3 Global RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
1.4.2 Global RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
1.4.3 Global RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
1.4.4 Global RNAi for Therapeutic Market Size and Growth Rate of Other from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of RNAi for Therapeutic Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of RNAi for Therapeutic by Major Types

3.4.1 RNAi for Therapeutic Market Size and Growth Rate of siRNA
3.4.2 RNAi for Therapeutic Market Size and Growth Rate of miRNA
3.4.3 RNAi for Therapeutic Market Size and Growth Rate of shRNA

4 Segmentation of RNAi for Therapeutic Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of RNAi for Therapeutic by Major End-Users

4.4.1 Market Size and Growth Rate of RNAi for Therapeutic in Cancer
4.4.2 Market Size and Growth Rate of RNAi for Therapeutic in Cardiovascular
4.4.3 Market Size and Growth Rate of RNAi for Therapeutic in HBV
4.4.4 Market Size and Growth Rate of RNAi for Therapeutic in Other

5 Market Analysis by Major Regions

5.1 Global RNAi for Therapeutic Production Analysis by Major Regions
5.2 Global RNAi for Therapeutic Consumption Analysis by Major Regions
5.3 Global RNAi for Therapeutic Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis
5.3.2 Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa RNAi for Therapeutic Production, Import, Consumption and Export Analysis

6 Product Commodity of RNAi for Therapeutic Market in Major Countries

6.1 Top 5 Export Countries in RNAi for Therapeutic market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in RNAi for Therapeutic market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

6.2 Top 5 Import Countries in RNAi for Therapeutic market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in RNAi for Therapeutic market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America RNAi for Therapeutic Landscape Analysis

7.1 North America RNAi for Therapeutic Landscape Analysis by Major Types
7.2 North America RNAi for Therapeutic Landscape Analysis by Major End-Users
7.3 North America RNAi for Therapeutic Landscape Analysis by Major Countries

7.3.1 United States RNAi for Therapeutic Market Volume and Growth Rate
7.3.2 Canada RNAi for Therapeutic Market Volume and Growth Rate
7.3.3 Mexico RNAi for Therapeutic Market Volume and Growth Rate

8 Europe RNAi for Therapeutic Landscape Analysis

8.1 Europe RNAi for Therapeutic Landscape Analysis by Major Types
8.2 Europe RNAi for Therapeutic Landscape Analysis by Major End-Users
8.3 Europe RNAi for Therapeutic Landscape Analysis by Major Countries

8.3.1 Germany RNAi for Therapeutic Market Volume and Growth Rate
8.3.2 UK RNAi for Therapeutic Market Volume and Growth Rate
8.3.3 France RNAi for Therapeutic Market Volume and Growth Rate
8.3.4 Italy RNAi for Therapeutic Market Volume and Growth Rate
8.3.5 Nordic Countries RNAi for Therapeutic Market Volume and Growth Rate
8.3.6 Spain RNAi for Therapeutic Market Volume and Growth Rate
8.3.7 Belgium RNAi for Therapeutic Market Volume and Growth Rate
8.3.8 Poland RNAi for Therapeutic Market Volume and Growth Rate
8.3.9 Russia RNAi for Therapeutic Market Volume and Growth Rate
8.3.10 Turkey RNAi for Therapeutic Market Volume and Growth Rate

9 Asia Pacific RNAi for Therapeutic Landscape Analysis

9.1 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major Types
9.2 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major End-Users
9.3 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major Countries

9.3.1 China RNAi for Therapeutic Market Volume and Growth Rate
9.3.2 Japan RNAi for Therapeutic Market Volume and Growth Rate
9.3.3 Australia and New Zealand RNAi for Therapeutic Market Volume and Growth Rate
9.3.4 India RNAi for Therapeutic Market Volume and Growth Rate
9.3.5 ASEAN Countries RNAi for Therapeutic Market Volume and Growth Rate
9.3.6 South Korea RNAi for Therapeutic Market Volume and Growth Rate

10 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis

10.1 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major Countries

10.3.1 GCC Countries RNAi for Therapeutic Market Volume and Growth Rate
10.3.2 Brazil RNAi for Therapeutic Market Volume and Growth Rate
10.3.3 Nigeria RNAi for Therapeutic Market Volume and Growth Rate
10.3.4 South Africa RNAi for Therapeutic Market Volume and Growth Rate
10.3.5 Argentina RNAi for Therapeutic Market Volume and Growth Rate

11 Major Players Profile

11.1 Alnylam Pharmaceuticals

11.1.1 Alnylam Pharmaceuticals Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

11.2 Arbutus Biopharma (Tekmira)

11.2.1 Arbutus Biopharma (Tekmira) Company Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction

11.3 Arrowhead

11.3.1 Arrowhead Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction

11.4 Dicerna Pharmaceuticals

11.4.1 Dicerna Pharmaceuticals Company Profile and Recent Development
11.4.2 Market Performance
11.4.3 Product and Service Introduction

11.5 Mirna Therapeutics

11.5.1 Mirna Therapeutics Company Profile and Recent Development
11.5.2 Market Performance
11.5.3 Product and Service Introduction

11.6 Quark Pharmaceuticals

11.6.1 Quark Pharmaceuticals Company Profile and Recent Development
11.6.2 Market Performance
11.6.3 Product and Service Introduction

11.7 RXi Pharmaceuticals

11.7.1 RXi Pharmaceuticals Company Profile and Recent Development
11.7.2 Market Performance
11.7.3 Product and Service Introduction

11.8 Silence Therapeutics

11.8.1 Silence Therapeutics Company Profile and Recent Development
11.8.2 Market Performance
11.8.3 Product and Service Introduction

11.9 Benitec Biopharma

11.9.1 Benitec Biopharma Company Profile and Recent Development
11.9.2 Market Performance
11.9.3 Product and Service Introduction

11.10 miRagen Therapeutics

11.10.1 miRagen Therapeutics Company Profile and Recent Development
11.10.2 Market Performance
11.10.3 Product and Service Introduction

11.11 Sylentis

11.11.1 Sylentis Company Profile and Recent Development
11.11.2 Market Performance
11.11.3 Product and Service Introduction

11.12 Gradalis

11.12.1 Gradalis Company Profile and Recent Development
11.12.2 Market Performance
11.12.3 Product and Service Introduction

11.13 Sirnaomics

11.13.1 Sirnaomics Company Profile and Recent Development
11.13.2 Market Performance
11.13.3 Product and Service Introduction

11.14 Silenseed

11.14.1 Silenseed Company Profile and Recent Development
11.14.2 Market Performance
11.14.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 106 Figures and 168 Tables)

Figure Product Picture
Figure RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
Figure RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
Figure RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Global RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Global RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
Figure Global RNAi for Therapeutic Market Size and Growth Rate of Other from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure France RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure India RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of RNAi for Therapeutic
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of RNAi for Therapeutic by Different Types from 2014 to 2026
Table Consumption Share of RNAi for Therapeutic by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of siRNA
Figure Market Size and Growth Rate of miRNA
Figure Market Size and Growth Rate of shRNA
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of RNAi for Therapeutic by Different End-Users from 2014 to 2026
Table Consumption Share of RNAi for Therapeutic by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Cancer
Figure Market Size and Growth Rate of Cardiovascular
Figure Market Size and Growth Rate of HBV
Figure Market Size and Growth Rate of Other
Table Global RNAi for Therapeutic Production by Major Regions
Table Global RNAi for Therapeutic Production Share by Major Regions
Figure Global RNAi for Therapeutic Production Share by Major Regions in 2014
Figure Global RNAi for Therapeutic Production Share by Major Regions in 2018
Figure Global RNAi for Therapeutic Production Share by Major Regions in 2026
Table Global RNAi for Therapeutic Consumption by Major Regions
Table Global RNAi for Therapeutic Consumption Share by Major Regions
Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2014
Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2018
Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2026
Table North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis
Table Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis
Table Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa RNAi for Therapeutic Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in RNAi for Therapeutic market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in RNAi for Therapeutic market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in RNAi for Therapeutic market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in RNAi for Therapeutic market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America RNAi for Therapeutic Consumption by Types from 2014 to 2026
Table North America RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
Figure North America RNAi for Therapeutic Consumption Share by Types in 2014
Figure North America RNAi for Therapeutic Consumption Share by Types in 2018
Figure North America RNAi for Therapeutic Consumption Share by Types in 2026
Table North America RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
Table North America RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2014
Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2018
Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2026
Table North America RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026
Table North America RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026
Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2014
Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2018
Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2026
Figure United States RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Canada RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Mexico RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Table Europe RNAi for Therapeutic Consumption by Types from 2014 to 2026
Table Europe RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
Figure Europe RNAi for Therapeutic Consumption Share by Types in 2014
Figure Europe RNAi for Therapeutic Consumption Share by Types in 2018
Figure Europe RNAi for Therapeutic Consumption Share by Types in 2026
Table Europe RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
Table Europe RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2014
Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2018
Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2026
Table Europe RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026
Table Europe RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026
Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2014
Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2018
Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2026
Figure Germany RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure UK RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure France RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Italy RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Belgium RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Poland RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Russia RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Turkey RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific RNAi for Therapeutic Consumption by Types from 2014 to 2026
Table Asia Pacific RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2014
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2018
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2026
Table Asia Pacific RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
Table Asia Pacific RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2014
Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2018
Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2026
Table Asia Pacific RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026
Table Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2014
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2018
Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2026
Figure China RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandRNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure India RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure South Korea RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2026
Figure GCC Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Brazil RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure South Africa RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Figure Argentina RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Alnylam Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
Table Product and Service Introduction of Alnylam Pharmaceuticals
Table Company Profile and Development Status of Arbutus Biopharma (Tekmira)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma (Tekmira)
Figure Sales and Growth Rate Analysis of Arbutus Biopharma (Tekmira)
Figure Revenue and Market Share Analysis of Arbutus Biopharma (Tekmira)
Table Product and Service Introduction of Arbutus Biopharma (Tekmira)
Table Company Profile and Development Status of Arrowhead
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead
Figure Sales and Growth Rate Analysis of Arrowhead
Figure Revenue and Market Share Analysis of Arrowhead
Table Product and Service Introduction of Arrowhead
Table Company Profile and Development Status of Dicerna Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals
Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals
Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals
Table Product and Service Introduction of Dicerna Pharmaceuticals
Table Company Profile and Development Status of Mirna Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirna Therapeutics
Figure Sales and Growth Rate Analysis of Mirna Therapeutics
Figure Revenue and Market Share Analysis of Mirna Therapeutics
Table Product and Service Introduction of Mirna Therapeutics
Table Company Profile and Development Status of Quark Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals
Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals
Figure Revenue and Market Share Analysis of Quark Pharmaceuticals
Table Product and Service Introduction of Quark Pharmaceuticals
Table Company Profile and Development Status of RXi Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals
Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals
Figure Revenue and Market Share Analysis of RXi Pharmaceuticals
Table Product and Service Introduction of RXi Pharmaceuticals
Table Company Profile and Development Status of Silence Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics
Figure Sales and Growth Rate Analysis of Silence Therapeutics
Figure Revenue and Market Share Analysis of Silence Therapeutics
Table Product and Service Introduction of Silence Therapeutics
Table Company Profile and Development Status of Benitec Biopharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma
Figure Sales and Growth Rate Analysis of Benitec Biopharma
Figure Revenue and Market Share Analysis of Benitec Biopharma
Table Product and Service Introduction of Benitec Biopharma
Table Company Profile and Development Status of miRagen Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics
Figure Sales and Growth Rate Analysis of miRagen Therapeutics
Figure Revenue and Market Share Analysis of miRagen Therapeutics
Table Product and Service Introduction of miRagen Therapeutics
Table Company Profile and Development Status of Sylentis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sylentis
Figure Sales and Growth Rate Analysis of Sylentis
Figure Revenue and Market Share Analysis of Sylentis
Table Product and Service Introduction of Sylentis
Table Company Profile and Development Status of Gradalis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis
Figure Sales and Growth Rate Analysis of Gradalis
Figure Revenue and Market Share Analysis of Gradalis
Table Product and Service Introduction of Gradalis
Table Company Profile and Development Status of Sirnaomics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics
Figure Sales and Growth Rate Analysis of Sirnaomics
Figure Revenue and Market Share Analysis of Sirnaomics
Table Product and Service Introduction of Sirnaomics
Table Company Profile and Development Status of Silenseed
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silenseed
Figure Sales and Growth Rate Analysis of Silenseed
Figure Revenue and Market Share Analysis of Silenseed
Table Product and Service Introduction of Silenseed

REPORTS

Let’s Pullulate and Expand Your Business